Objectives: To describe the risk factors associated with death in pregnant women with severe pandemic H1N1 infection.
INTRODUCTION
As in the documented influenza epidemics and pandemics, particularly the 2009 pandemic A (H1N1), pregnant women appear to be at increased risk of severe diseases. [1] [2] [3] [4] [5] [6] [7] [8] The effects of influenza during pregnancy have been noted in previous pandemics, particularly the increased mortality in pregnant women compared with the general population. 9 Health Ministry of China issued 'Diagnosis and Treatment of Pandemic Influenza A(H1N1) (Trial Second Edition)' on July 10, 2009 declaring the pregnant women belonged to the highest-risk group of pandemic influenza A(H1N1) infection.
From June 19, 2009 to April 25, 2011, 43% of the total cases with severe p(H1N1) infection reported to a web-based Anhui provincial influenza surveillance system were pregnant. 15% of the severe p(H1N1) cases during pregnancy or puerperium died.
How to decrease the mortality of the p(H1N1) severe cases in particular to the pregnant women , has been a crucial problem even though the authority of public health in China had adjusted the control measures and administrative strategies for controlling the p(H1N1) epidemics based on the different stages of the pandemic. However, the global H1N1 influenza pandemic disproportionately affected pregnant women, drawing attention to the fact that although they need safe and effective medical treatment, they have always been a marginalized study population. 10 To know more about the risk factors associated with pregnant women with p(H1N1) infection, we conducted an individual investigation to all the cases reported to the Anhui provincial influenza surveillance system from June 19 ,2009 to April 25, 2011.
This article aimed to describe the characteristics of the pregnant women with severe p(H1N1) infection and the possible risk factors associated with their death.
METHODS

Data sources and participants
Since the Health Ministry of China declared the first p(H1N1) case reported occurring in mainland of China on May 11,2009 , the national influenza surveillance system had been further enhanced and expanded to more areas all over the country. Until June, 2009, China had set up 282 national sentinel hospitals in southern China and 274, northern China. Anhui province, located in southern China, had established 25 (9% of all the southern provinces in China) national sentinel hospitals in all 17 prefecture cities since June, 2009.
All the professionals in the sentinel hospitals and CDCs of Anhui were trained on the field epidemiological investigation by using the uniform questionnaire designed by the China CDC. Cases diagnosed by the local sentinel hospitals were reported to the local CDC and their samples, collected by the clinicians, were submitted to the network laboratory of the national influenza surveillance system to do the laboratory test. The severe case needed to be confirmed by a panel consisting of the local sentinel hospital's clinicians and CDC's epidemiological experts. The severe cases were investigated by the local CDC epidemiologists using the uniform questionnaire in the appendix of 'National p(H1N1) influenza surveillance guideline (the second edition)' and then submitted to 'the Chinese Influenza Surveillance Information System'.
A review was conducted for all the severe cases of p (H1N1), pregnant or postpartum, reported to Anhui provincial influenza surveillance system from June 19, 2009 to April 25. However, the pregnant women's underlying medical conditions, particularly of the dead cases could not have been collected.
Case definition
A case of p(H1N1) infection was defined as a patient with influenza-like symptoms confirmed by one or more of the followings: reverse-transcriptase-polymerase-chain-reaction (RT-PCR) or reverse-transcriptase-polymerase-chain-reaction (RT-PCR); isolation of p(H1N1) virus; four folds or more increase of the specific antibody of the case's double blood serum.
A severe case of p(H1N1) infection was defined as a case with at least one of the following symptoms: high fever more than 3 days; purulent, blood stained sputum or chest pain; dyspnea or cyanotic lips; alerted mental ( unresponsive, lethargy, restlessness or eclampsia); severe vomiting, diarrhea and dehydration; pneumonia by imaging examination; quick increase of cardiac enzyme, such as creatine kinase, creatine kinase isozymes; respiratory failure; infective toxic shock; multiple organ dysfunction syndrome; admission to intensive care unit.
A fatal case of p(H1N1) infection was defined as confirmed p(H1N1) infection in a severe case who died or whose death certificate listed p(H1N1) influenza as a major or underlying cause of death.
A severe pregnant case was a severe case during pregnancy. Patients were excluded if they had been treated as outpatients or in emergency rooms, had duration of hospitalization <24 hours or there was an incomplete record of clinical outcome.
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All the pregnant cases were divided into 2 groups, death and surviving groups. The case control studies were conducted between the two groups to know their difference in characteristics and treatment.
Statistical analysis
Analysis was conducted using SPSS 15.0 (Statistical Package for the Social Sciences) for Windows. The median were calculated by Wilcoxon rank-sum test , a Fisher's Exact test or an independent-sample T test. 
RESULTS
Of 3436 cases, reported from
Association between mortality and trimester
Of the 46 pregnant patients, 6(13%) were in the first trimester, 5 (11%) were in the second trimester and 35(76%) in the third trimester. Of the 7 pregnant women who died from the p(H1N1) infection, 5 (70%) cases were in the third trimester.
Association between mortality and age
The pregnant women in the death group varied from 18 to 31 years, and 18-27 years in the surviving group and no significant difference in age was found between the two groups (P=0.12). The median of age was both 21 years in either death or surviving group showing no significant difference between them (P=0.96). The results were showed in Table 1 .
Association between mortality and admission time
The time interval from onset to death ranged from 6 to 31 days and the median was 18 days in the death group while in the surviving group, the duration of onset to recovery varied from 5 to 39 days and the median was 14 days.
29 (63%) cases in the surviving group were admitted to hospital within 3 days after onset while only 1 (2%) case in the death group took the earliest admission 2 days after the onset. There was a significant difference on how soon to be admitted between the death and the surviving group (OR:0.09; 95%CI:0.01-0.68). Median time of admission to hospital in the death group was 4 days after onset and the surviving group, 2 days. The difference between them was significant (P=0.004) showed in Table 1 . +,one-sided independent-sample T test.
Association between mortality and antiviral treatment
The pregnant cases who died from the severe p(H1N1) infection were given antiviral treatment in 2 to 8 days after onset and the surviving pregnant cases were prescribed antiviral drugs on the first day of onset to 7 days after onset. 70% of surviving cases were given antiviral drugs within 3 days after onset but only 2% of the death cases were treated by antiviral drugs over the same time period and the other death cases were all treated more than 3 days after onset. There was a significant difference in time for being given antiviral drugs between the death and surviving group (OR:0.06; 95%CI:0.01-0.41). The median of time interval from onset to antiviral treatment was 5 days in the death group and 3 days in the surviving group showing a significant difference (P=0.0054).
The death cases were given antiviral drugs in a range of 1-11 days and the surviving cases, 2-11 days. 4% of the death cases and 24% of the surviving cases were taken the antiviral drugs no more than 3 days. There was no significant difference of time duration from onset to antiviral treatment between the death and the surviving group (OR: 0.95; 95%CI: 0.21-4.30) and the median was 5 days either in the death group or the surviving group. No significant difference appeared between the death and the surviving group in the median of time duration for antiviral treatement (P=0.32). The results were showed in Table 1 .
Associations between mortality and corticosteroids therapy
The death cases were given corticosteroids therapy in a range of 1-9 days after onset and the surviving cases, on the first day of onset to 9 days after onset. 1 (4%) death case and 11 (41%) surviving cases were taken corticosteroids within 3 days after onset and there was no significant difference in time duration from onset to corticosteroids therapy between the death group and the surviving group (OR:0.25;95%CI:0.03-1.86). The median of time duration from onset to corticosteroids therapy was 5 days in the death group and 3 days in the surviving group showing no significant difference between them(P=0.056).
The death cases were given corticosteroids therapy in a range of 2-17 days and the surviving cases, 1-5 days. 3(7%) death cases and 14 (30%) surviving cases were treated by corticosteroids therapy in time ranging from 3 to 5 days. There was no significant difference in time duration from onset to corticosteroids therapy between the death and the surviving group (P=0.44). The medians of time duration of corticosteroids therapy were both 3 days either in the death or surviving group showing no significant difference between them (P=0.55).
DISCUSSION
Since the first case with p(H1N1) infection was reported on Jun 19,2009 in Anhui province, China, a total of 126 severe cases of p(H1N1) had been reported till Apr 30, 2010 including 46 (37%) pregnant cases. And the case-fatality rate of pregnant women with p(H1N1) infection was around 15%, which was 4% higher than the mortality of the severe cases of p(H1N1). Pregnant women were considered to be at the highest risk group during the 2009 H1N1 pandemic.
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Compared to the non-pregnant cases, the pregnant cases were more likely to develop complications, such as pneumonia and ARDS. As for the pregnant cases, the decreasing adjuvanticity T cells and the falling activity of NK cell both can result in compromising the immune response system. Furthermore, the increscent womb and uplifted diaphragm can weaken the capacity of cleaning the secretion of respiratory track and decrease the lung's remaining air as well. Nevertheless, the pregnant women need more oxygen but their lungs are filled with more liquid. All of these could cause the pregnant cases more susceptible to complication. In addition, the severity and the time course of pneumonia occurred in the pregnant cases were 9 times more than and 3 times longer than the non-pregnant cases. Vaccination during pregnancy is not contraindicated and therefore can be considered.
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Of 46 pregnant patients, 35(76%) were in their third trimester. Among the 7 pregnant women who died from p(H1N1) infection, 5 (70%) cases were in their third trimester. So the third trimester was at the highest-risk time period for the pregnant women to infect p(H1N1) or suffer from more severe outcomes. This is consistent with the observation of influenza-associated with excess deaths among pregnant women during the previous pandemics, with risk increasing with advancing stages of pregnancy.
In the third trimester, the rapidly-developing fetus overburdens its mother consuming more oxygen. In addition, pregnant women in the third trimester were more concerned on having X-ray tests so there are possibility of misdiagnosing them. 13 Consequently, the pregnant women in the third trimester probably face the higher risk than the first two trimesters.
In the death group, the median of the time interval from onset to death was 18 days. In the surviving group, the time duration from onset to recovery varied from 5 to 39 days and the median was 14 days. It shows if the pregnant women with severe infection of pandemic H1N1 cannot be cured after 2-week treatment, we need pay much more attention to preventing them from dying in the next several days.
The pregnant women with p(H1N1) infection showed no significant difference in age between the death group and the surviving group and the median of age in two groups were both 21 years. However, in the review of a large number of hospitalized and fatal cases of pandemic 2009 influenza A(H1N1) infection in California, the median age was 27years. 17 The difference of median age between Anhui and California probably needs to be studied further.
The pregnant women in the surviving group were admitted to hospital significantly earlier than the death group showing an early admission was critical for the severe pregnant cases to reduce the possibility of fatality. During our investigation we asked the cases or their family members the reasons of the pregnant women with p(H1N1) infection to delay their admission to hospital and knew several possible reasons as followings: Firstly, they were afraid they would more likely be exposed to the respiratory infectious diseases by close contacts with the patients while visiting a doctor of respiratory medicine. Secondly, they were concerned with the possible side effects on their baby while taking some western medicine so they would rather seek help from a local Chinese traditional medicine expert. Lastly, they onset the influenza-likely symptoms resembling the common cold so they didn't think it was really necessary to seek medical care immediately.
In this study, the pregnant cases who finally recovered from the severe p(H1N1) infection were given the antiviral drugs earlier than the pregnant cases who died but there was no significant difference in the time duration of treatment. Probably, to give antiviral treatment as soon as possible was critical to prevent the pregnant cases from death. This is in accordance with the previous studies showing antiviral therapy is the most beneficial when treatment is initiated within 48 hours after the onset of illness. 18 However, according to our results, a time course of antiviral treatment was enough and there was no need to extend the extra time of treatment. Considering the limitations of our report, this should be further studied to confirm it.
In terms of corticosteroids therapy, no significant difference was seen between the death group and the surviving group either in how soon or how long to use it so maybe it is unnecessary to be chosen for treating the pregnant cases with severe p(H1N1) infection.
Additionally, in the concerns of the side-effect of corticosteroids on the human healthcompromising the immune system, the corticosteroids treatment probably should not be recommended to the severe pregnant women with p (H1N1) infection for shrinking the possibility of death.
LIMITATIONS
Our estimates may not be generalized to the rest of the severe pregnant cases infected by pandemic H1N1 as the relatively small sample limited the ability of extrapolation. Also, the severe pregnant women who did not undergo routine prenatal screening or who visited the other hospitals that were not our sentinel hospitals were not represented. Additionally, comorbidity records were not generally available, particularly for fatal cases.
CONCLUSION
For the pregnant cases with severe p(H1N1) infection, the risk factors associated with death were as following: the delayed use of antiviral drug, being in the third trimester. The corticosteroids use appeared no effect on preventing the severe pregnant cases from dying. And, vaccination is an effective measure to prevent the pregnant women from getting infection of p(H1N1).
This article adds confirmatory data to that reported in previous studies [19] [20] which suggest s that early admission and antiviral drug treatment are to be recommended and that more than one course of antiviral treatment and corticosteroids might be unhelpful in reducing the possibility of a fatal outcome.
